Back to News
Mar 10, 2026 8:00 AM

Prelude Therapeutics Earnings Report: Q4 Overview

Prelude Therapeutics (NASDAQ:PRLD) announced its Q4 earnings on Tuesday, March 10, 2026 at 07:01 AM.

Here's a breakdown of the earnings report.

Earnings

Prelude Therapeutics beat estimated earnings by 16.67%, reporting an EPS of $-0.2 versus an estimate of $-0.24.

Revenue was up $1.64 million from the same period last year.

Analysis of Past Earnings

Last quarter the company beat on ...